Endometrial stromal sarcoma with Cd56 expression: a case report
Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pusat Perubatan Universiti Kebangsaan Malaysia
2018
|
| Online Access: | http://journalarticle.ukm.my/12555/ http://journalarticle.ukm.my/12555/ http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf |
| id |
ukm-12555 |
|---|---|
| recordtype |
eprints |
| spelling |
ukm-125552019-02-14T21:32:17Z http://journalarticle.ukm.my/12555/ Endometrial stromal sarcoma with Cd56 expression: a case report Azizan N, Hayati F, Madatang A, Abu Seman F, Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice, CD56 is not used to support the diagnosis of ESS. We present a case of a postmenopausal lady with advanced ESS who had expression of CD56 upon immunohistochemical study. Pusat Perubatan Universiti Kebangsaan Malaysia 2018 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf Azizan N, and Hayati F, and Madatang A, and Abu Seman F, (2018) Endometrial stromal sarcoma with Cd56 expression: a case report. Journal of Surgical Academia, 8 (1). pp. 36-38. ISSN 2231-7481 http://jsurgacad.com/toc/8/1 |
| repository_type |
Digital Repository |
| institution_category |
Local University |
| institution |
Universiti Kebangasaan Malaysia |
| building |
UKM Institutional Repository |
| collection |
Online Access |
| language |
English |
| description |
Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice, CD56 is not used to support the diagnosis of ESS. We present a case of a postmenopausal lady with advanced ESS who had expression of CD56 upon immunohistochemical study. |
| format |
Article |
| author |
Azizan N, Hayati F, Madatang A, Abu Seman F, |
| spellingShingle |
Azizan N, Hayati F, Madatang A, Abu Seman F, Endometrial stromal sarcoma with Cd56 expression: a case report |
| author_facet |
Azizan N, Hayati F, Madatang A, Abu Seman F, |
| author_sort |
Azizan N, |
| title |
Endometrial stromal sarcoma with Cd56 expression: a case report |
| title_short |
Endometrial stromal sarcoma with Cd56 expression: a case report |
| title_full |
Endometrial stromal sarcoma with Cd56 expression: a case report |
| title_fullStr |
Endometrial stromal sarcoma with Cd56 expression: a case report |
| title_full_unstemmed |
Endometrial stromal sarcoma with Cd56 expression: a case report |
| title_sort |
endometrial stromal sarcoma with cd56 expression: a case report |
| publisher |
Pusat Perubatan Universiti Kebangsaan Malaysia |
| publishDate |
2018 |
| url |
http://journalarticle.ukm.my/12555/ http://journalarticle.ukm.my/12555/ http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf |
| first_indexed |
2023-09-18T20:02:52Z |
| last_indexed |
2023-09-18T20:02:52Z |
| _version_ |
1777406965454995456 |